SCHEMBL9875622

SCHEMBL9875622

O=C1CCCc2nc3ccccc3c(NCc3ccc(C(F)(F)F)cc3)c21

nearest known ligand 0.63

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.54
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
HTT P42858 1/20 0.54
ACHE P22303 5/20 0.53
BCHE P06276 3/20 0.53
BACE1 P56817 1/20 0.53
APP P05067 2/20 0.50
USP1 O94782 1/20 0.45
WDR48 Q8TAF3 1/20 0.45
POLB P06746 1/20 0.44
RAD52 P43351 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9875886 0.90 ACHE (0.49) KDM4EKMT2AMEN1HTTACHE
SCHEMBL8984077 0.89 KMT2A (0.67) KDM4EKMT2AMEN1HTTACHE
SCHEMBL9875377 0.89 APP (0.53) KDM4EKMT2AMEN1HTTACHE
SCHEMBL9875822 0.88 KMT2A (0.57) KDM4EKMT2AMEN1HTTACHE
SCHEMBL9875000 0.86 KDM4E (0.57) KDM4EKMT2AMEN1HTTACHE
SCHEMBL9873820 0.86 KDM4E (0.57) KDM4EKMT2AMEN1HTTACHE
SCHEMBL9875620 0.83 KDM4E (0.46) KDM4EKMT2AMEN1HTTACHE
SCHEMBL15155440 0.83 KMT2A (0.54) KDM4EKMT2AMEN1HTTACHE
SCHEMBL10846227 0.83 KDM4E (0.51) KDM4EKMT2AMEN1HTTACHE
SCHEMBL9875649 0.83 MEN1 (0.54) KDM4EKMT2AMEN1HTTACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4695573-A COGNITION ACTIVATORS HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-09-22 US claimed
EP-2681554-B1 BLOOD COLLECTION DEVICE CONTAINING LYSOPHOSPHOLIPASE INHIBITOR BECTON DICKINSON CO (US) 2017-08-09 EP disclosed
US-9459187-B2 Blood collection device containing lysophospholipase inhibitor BECTON, DICKINSON AND COMPANY (US) 2016-10-04 US disclosed
US-20140030754-A1 BLOOD COLLECTION DEVICE CONTAINING LYSOPHOSPHOLIPASE INHIBITOR BECTON, DICKINSON AND COMPANY (US) 2014-01-30 US disclosed
US-20130209985-A1 SAMPLE COLLECTION DEVICES WITH BLOOD STABILIZING AGENTS BECTON, DICKINSON AND COMPANY 2013-08-15 US disclosed
EP-0179383-B1 9-AMINO-1,2,3,4-TETRAHYDROACRIDIN-1-OL AND RELATED COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-05-29 EP disclosed
US-4839364-A ALZHEIMER*S DISEASE; CHOLINESTERASE INHIBITORS HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-06-13 US disclosed
US-4835275-A Method of preparing 9-amino-1,2,3,4,-tetrahydroacridin-1-ones and related compounds HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-05-30 US disclosed
US-4754050-A COGNITION ACTIVATORS HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1988-06-28 US disclosed
US-4695573-A COGNITION ACTIVATORS HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-09-22 US disclosed
US-4631286-A MEMORY ENHANCERS HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1986-12-23 US disclosed
EP-0179383-A2 9-Amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1986-04-30 EP disclosed